Amgen to purchase psoriasis drug from Celgene for $13.4B
Amgen Inc. will pay $13.4 billion for a psoriasis drug from Celgene Corp., which is shedding the asset in order to win antitrust regulators' approval for its $74 billion merger…
More from Arkansas Business
Arkansas Democratic Gazette | Business
$60 million Riggs facility to generate 75 jobs, open in 2027
Arkansas Business
•
1d ago
Talk Business Arkansas
Inflation expected to push holiday sales above $1 trillion
Arkansas Business
•
1d ago
Talk Business Arkansas
Rogers to vote on $457 million bond for street, park projects
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
Arkansas Agriculture Hall of Fame accepting nominations
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
J.B. Hunt Transport Services Inc. reports $172.4 million quarterly profit
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
Rogers-based America's Car-Mart gets seventh extension on loan terms from original Sept. 7 deadline
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
Simmons First National reports $47.1 million third quarter profit
Arkansas Business
•
1d ago
